Hints and tips:
Related Special Reports
...We were trying to wake up Whitehall to the scale of the problem.”...
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
...A new “entity” in government would be responsible for dealing with potential investors and for bringing projects to fruition, removing the need for them to navigate Whitehall bureaucracy....
...The US drugmaker has spent almost $30bn on acquisitions over the past two years, snapping up Arena Pharmaceuticals, Biohaven Pharmaceuticals, Global Blood Therapeutics, ReViral and Trillium Therapeutics....
...The BCC has argued that the fragmented Whitehall funding pots covering the levelling up agenda should be consolidated and simplified....
...But only about one in seven of all the identified companies give their sector as pharmaceutical or scientific work....
...The Long Shot: The Inside Story of the Race to Vaccinate Britain, by Kate Bingham and Tim Hames, Oneworld £18.99, 336 pages Hannah Kuchler is the FT’s global pharmaceuticals correspondent Join our online...
...“The next test case many of us are watching is Pfizer’s acquisition of Arena Pharmaceuticals,” says Loncar....
...Chemicals and pharmaceuticals remain unaffected by sanctions....
...One senior Whitehall official said ministers wanted individuals to focus on “boosters and behaviour” before considering Plan B measures....
...Contingency planning is also under way in Whitehall, including for more stringent mask regulations and a potential work-from-home order....
...Frustration is also growing in Whitehall about the JCVI’s slow decision-making on a booster programme....
...Another senior Whitehall official confirmed that mixing doses was “how we’re going to do the autumn booster programme”....
...Oxford collaborated with the UK-based pharmaceutical company AstraZeneca to develop a leading Covid-19 vaccine....
...Whitehall officials and Pfizer said deliveries were taking place exactly as scheduled....
...Another Whitehall insider said there was an increasing sense that a “smallish delay” may be likely. “Irreversibility is key to this....
...Whitehall officials said there were “significant manufacturing issues” with both AstraZeneca and Moderna, with only Pfizer due to meet its delivery commitments....
...The Oxford/AstraZeneca vaccine is seen as game-changing within Whitehall, as its low price and ease of storage will allow the government to vaccinate people more quickly....
...Grimstone has been given a remit by the prime minister to work across Whitehall to remove barriers to potential investments in the UK....
...One person familiar with thinking in Whitehall suggested there was optimism that vaccination of priority groups such as NHS staff on the frontline of the fight against Covid-19 might be able to get under...
...With an estimated 50,000 new customs agents needed, Whitehall is baffled the industry has not taken up more of the £84m it made available to take on staff....
...A senior Whitehall official said there had been some “back and forth” on the issue within Whitehall as the Department for Business, Energy and Industrial Strategy weighed up the political sensitivities around...
...The pharmaceuticals industry responded in 2018 to the government’s edict that it create a stockpile of at least six weeks of medicines....
...Amid growing concern in Whitehall of chaos at the ports on January 1, Mr Johnson’s closest allies will this week discreetly attempt to see whether Brussels is willing to offer compromises to allow talks...
...The shift comes after the pharmaceutical industry warned the government that the Covid-19 pandemic would prevent them from rebuilding the six-week medicine stockpile of 2019, raising fears in Whitehall of...
International Edition